Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1383 of 5804
-
New combo therapy aims to tackle Hard-to-Treat myeloma
Disease control Recruiting nowThe purpose of this study is to establish a safe and tolerable dose of arlocabtagene autoleucel (BMS-986393) in combinations with alnuctamab, mezigdomide, iberdomide, and elranatamab in participants with relapsed and/or refractory multiple myeloma (RRMM).
Phase: PHASE1 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Super-Fine ultrasound could spare melanoma patients a second surgery
Diagnosis TerminatedCutaneous melanomas represent 4 to 11% of cutaneous cancers, but is responsible for 75% of the deaths reported for these pathologies. The incidence rate double every 10 years. Fourteen thousand cases and 1700 deaths were reported in France in 2015. The local staging of the cance…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Could a weekly shot stop post-transplant weight gain?
Prevention Recruiting nowIn this study, semaglutide will be compared to placebo (a look-alike inactive substance, a "sugar pill") to determine if its use will prevent weight gain after liver transplantation (LT). In addition, researchers will be testing to determine if semaglutide prevents the developmen…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Prevention
Last updated Jun 27, 2026 13:03 UTC
-
Exercise may sharpen memory in breast cancer survivors
Symptom relief Recruiting nowThis phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast cancer survivors report cancer-related cognitive impairment, which this has recently become a priority in clinical research due to its dramatic i…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Could a simple pill replace IV drips for serious blood infections?
Disease control Recruiting nowThe Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy for the treatment of Gram-Negative BloodStream Infection (GN-BSI) is as effective…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New ultrasound device aims to speed up dialysis access healing
Disease control Recruiting nowThis is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation.
Phase: NA • Sponsor: Sonavex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Recruiting nowThis study is designed as a single arm open label traditional Phase I, 3+3, study of CD4-directed chimeric antigen receptor engineered T-cells (CD4CAR) in subjects with relapsed or refractory CMML. Specifically, the study will evaluate the safety and feasibility of CD4CAR T-cells…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New Two-Drug HIV pill could match Three-Drug standard
Disease control OngoingThis study will compare safety, efficacy, participant reported outcomes and implementation outcomes of a fixed dose combination (FDC) of a two-drug regimen dolutegravir (DTG) plus lamivudine (3TC) and a three-drug regimen FDC of bictegravir (BIC), emtricitabine (FTC) and tenofovi…
Phase: PHASE3 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Breathing gas after heart surgery may stop deadly lung infection
Prevention CompletedThe primary aim of this single-center, prospective, randomized, controlled, study is to test the hypothesis that inhalation of NO 200 ppm prevents the development of nosocomial pneumonia in patients at risk after cardiac surgery under CPB. The study is interventional. Examination…
Phase: NA • Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Prevention
Last updated Jun 27, 2026 14:03 UTC
-
Could a 12-Month break from prostate cancer drugs be enough?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the outcomes of a shorter treatment duration (12 months) with an androgen receptor pathway inhibitor (ARPI), in this study Apalutamide or Enzalutamide, in patients with low-volume, hormone-sensitive metastatic prostate cancer (mCSPC)…
Phase: PHASE3 • Sponsor: Nick Beije • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for rare heart disease: experimental drug tested for long-term safety
Disease control OngoingThis study will test a medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis. It will look at how safe this medicine is in the long term and if it can reduce symptoms of a heart disease due to TTR amyloidosis, such as heart failure. It is an extension…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Cash and texts: a new way to help older smokers kick the habit?
Disease control OngoingThis study aims to assess the effect of mobile health (mHealth) support or financial incentives and their interactive intervention effect on smoking cessation (SC) in old smokers in Hong Kong (HK).
Phase: NA • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Ultrasound zaps lung nerves to ease heart failure symptoms
Disease control ENROLLING_BY_INVITATIONThis early feasibility study is intended to characterize the impact of pulmonary artery denervation on the quality of life in Heart Failure Patients with Group 2 Pulmonary Hypertension
Phase: NA • Sponsor: Gradient Denervation Technologies • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New immune cell combo aims to stop leukemia relapse
Disease control Recruiting nowThe purpose of this research study is to test the safety and to explore the effectiveness of infusing cytokine- induced memory-like (CIML) natural killer (NK) cells in combination with Interleukin-2 (IL-2) and standard-of-care venetoclax as a treatment for Acute Myeloid Leukemia …
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Could a neck device curb opioid withdrawal?
Symptom relief Recruiting nowThis study is being done to answer the question: what is the effect of Vagal Nerve Stimulation (VNS) dosing on opioid withdrawal responses in individuals with a history of Opioid Use Disorders (OUDs)? Eligible participants will be in the study for one week in an inpatient researc…
Phase: PHASE3 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Tailored brain zaps could help Parkinson's patients walk better
Symptom relief Recruiting nowThe objective of this study was to determine the effects of protocols of repetitive transcranial magnetic stimulation (rTMS) therapy based on the functional reserve of each patient with Parkinson's disease, compared to conventional high-frequency rTMS therapy on bilateral primary…
Phase: NA • Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New hope for rare tumor patients: chemo delivered directly to desmoid growths
Disease control Recruiting nowDesmoid fibromatoses are rare (1-2 cases/million per year) and locally aggressive mesenchymal tumors. For asymptomatic disease, current guidelines suggest an initial period of active surveillance. The current scientific evidence regarding the efficacy and safety of the treatment…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug aims to cut dangerous lung Flare-Ups in bronchiectasis patients
Disease control CompletedACT18018 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 2 study with 3 treatment groups. The purpose of this study is to evaluate efficacy, safety and tolerability with 2 dosing regimens of itepekimab compared with placebo in male and/or f…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New Two-Drug combo targets Hard-to-Treat myeloma in early trial
Disease control Recruiting nowThe main purpose of the study is to understand how safe and tolerable is elranatamab when given along with iberdomide. There are 2 parts to this study. Part 1 will look at how safe and tolerable is elranatamab when given with iberdomide. Part 2 will look at the correct amount of…
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New heart device aims to cut stroke risk in AFib patients
Disease control TerminatedThe purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) device as compared to the commercially available LAAC devices in participants with non-valvular atrial fibrillation (NVAF) to reduce the risk of stroke (blocked bl…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC